Skip to main content

red, white, and breast cancer

The red vs white debate is enough to make me blue. Red wine, with very few exceptions, has much higher levels of the polyphenols to which many but not all of wine's benefits are attributed. In recent weeks, reports came out that it didn't matter whether it was even wine or any other alcoholic drink, breast cancer risk was apparently raised by as little as a glass a day. As I have pointed out in previous posts, there are too many problems with the way the data for these studies is gathered to say anything that definitive, but now a study from the Fred Hutchinson Cancer Research Center here in Seattle weighs in with the red vs white wine question. They were particularly interested because earlier studies from the Hutch (as we call it here) found that red wine drinking correlated to lowered odds of prostate cancer in men, and a large body of research suggests that wine polyphenols are effective at countering breast cancer.

The study, funded by the National Cancer Institute, was looking for reduced risk of breast cancer with red wine. What they found was that more than 14 drinks per week correlated to an increase of 24% in breast cancer incidence, regardless of type. The authors were careful it appears to not make the mistake that many others do in interpreting the data, however, which is to extrapolate backwards from 2 drinks per day equalling 24% risk to 1 drink implying a 10-12% risk. The reason it is a mistake is that there is no way of measuring self-reported behavioral data that accurately so the effects of a drink a day are essentially unknowable. This is especially true because there are so many other studies showing that moderate drinking is beneficial, in terms of cancer risk and many other health factors. And of course there are few people who really only drink one type of alcoholic beverage and in the same amounts every day.

The authors did recommend that women should limit drinking to one per day, which is probably sensible especially if you are in a higher than average cancer risk category. I'm still in the red wine camp, at least where healthy drinking is concerned.

Comments

Popular posts from this blog

Versatile resveratrol: the ultimate skin care ingredient?

  Part 1 Recently I was honored to join Professors David Sinclair of Harvard and Joseph Vercauteren of the University of Montpelleir at an anti-aging symposium at the invitation of Mathilde Thomas of Caudalie in Paris. Caudalie has been using wine extracts (and specifically resveratrol) in their products for more than 15 years, after Vercauteren identified it in wine grape vines. Sinclair has become well known for his work identifying the role of sirtuin (SIRT) genes in anti-aging, and resveratrol as a natural sirtuin activator. While much remains to be proven, it is fair to say that science is finally beginning to have an impact on skin care. With an increasing understanding of what causes aging in skin cells and how botanical antioxidants such as resveratrol work at a molecular level, there is no excuse to use anti-aging skin care products that don’t multitask. Before delving into the potential benefits of resveratrol in skin care, it may help to review ho...

Revisiting resveratrol: new findings rekindle anti-aging debate

Just when we thought the bloom was off the rosé for resveratrol, the anti-oxidant polyphenol from red wine with multiple anti-aging properties, along comes new research giving life to the debate. But first a bit of background: As I detailed in my book Age Gets Better with Wine , it is well-documented that wine drinkers live longer and have lower rates of many diseases of aging. Much or the credit for this has been given to resveratrol, though there isn’t nearly enough of it in wine to explain the effects. Nevertheless, I dubbed it the “miracle molecule” and when it was reported to activate a unique life-extension phenomenon via a genetic trigger called SIRT, an industry was born, led by Sirtris Pharmaceuticals, quickly acquired by pharma giant Glaxo. The hope was that resveratrol science could lead to compounds enabling people to live up to 150 years and with a good quality of life. But alas, researchers from other labs could not duplicate the results, and clinical studies disa...